LLA is a well-recognized supplemental drink that has been used in Japan and China for decades. We previously found that LLA significantly increased SOD and GSH levels in the spleen and liver[16], suggesting the antioxidative activity of LLA. Notably, ROS plays an important role in the progression of inflammation, which leads to the cell's malignant transformation. Moreover, polyphenols, which are the major effector molecules in fruits, exhibit cancer-preventive effects, mostly through their anti-inflammatory properties[24]. As a result, it is reasonable to speculate that LLA may have an anti-inflammatory effect and thus aid in cancer prevention. As expected, we found that LLA exhibited a potent anti-inflammatory effect in the DSS-induced mouse inflammatory colitis model (Fig. 1), in which the symptoms and pathological changes were remarkably improved by LLA (Fig. 1), and inflammatory cytokine production was significantly suppressed (Fig. 2). In line with the anti-inflammatory activity of LLA, carcinogenesis induced by AOM/DSS, which is a typical model of inflammation-related carcinogenesis, was markedly inhibited by LLA administration (Fig. 4), indicating the strong potential of LLA for cancer prevention.
In this study, we did not find a direct anticancer effect of LLA: feeding LLA to mice bearing solid tumors did not suppress tumor growth significantly (Fig. 3b). However, previous studies have indicated the antitumor activities of traditional Chinese medicine in LLA. For example, the fruit extract of Phyllanthus emblica has long been used in traditional medicine to treat many diseases, such as constipation and cancer[25]. From the leaves, roots, and fruit juice of Phyllanthus emblica, 18 main components have been extracted and identified, such as phyllaemblicin B, phyllaemblicin C, and phyllemtannin, most of which showed potent tumoricidal effects against many tumor cells[5]. In addition, the oil extract of Coicts semen, Kanglaite injection, not only shows an anticancer effect but can also largely enhance the host's immune function, which was approved in 1997 by the Ministry of Health of China for treating many cancers: over millions of cancer patients in more than 2,000 hospitals in China have been treated with Kanglaite injection[10,26]. It is not clear why LLA had no significant anticancer effect, but we believe that dosing is the main reason. Namely, the above-mentioned studies used a condensed extract of traditional medicines at relatively high concentrations; however, the LLA used in our present study was a supplement drink containing the hot water extract of seven Chinese traditional medicines, which was used and evaluated as a whole as a healthy supplement but not as a pharmaceutical agent. This means that the active components in LLA that may have exhibited tumoricidal effects were very limited. In addition, the dosing in this study was comparable to the commonly suggested amount of this supplement drink (e.g., the dose of 0.6% is comparable to 135 ml per day in humans). Thus, by the protocol used in this study, the effector components with anticancer effects could not reach or were much lower than the cytotoxic doses. Future studies are warranted to identify the anticancer components of LLA and to elucidate the potential of LLA for cancer treatment.
Although we did not find an apparent anticancer effect of LLA, its potential for cancer prevention was found. LLA administration before tumor formation significantly inhibited tumor occurrence and growth (Fig. 3a), and feeding LLA to the mice remarkably suppressed the colon cancer carcinogenesis triggered by carcinogen AOM/DSS (Fig. 4) that mimics the process of human cancer development. Regarding the possible mechanisms of action for the cancer-preventive effect of LLA, we did not find an apparent cytotoxic activity of LLA (Fig. 5) or observe its effect on macrophage activation (Fig. 6), suggesting that cytotoxicity and activation of innate immunity are not involved in the cancer-preventive effect of LLA. In a previous study using LLA, our group found that LLA exhibited a potent antioxidative effect by increasing the activity of the antioxidative enzyme SOD and the amount of antioxidant GSH[16], indicating the anti-inflammatory potential of LLA. As expected, we found a remarkable anti-inflammatory effect of LLA in the DSS-induced mouse colitis model (Figs 3, 4). Unexpectedly, we did not observe significant changes in the cellular redox status, as measured by the levels of GSH and ROS, in cancer cells after LLA treatment under normal conditions (Supplemental Fig. S1). However, we made an important discovery when examining the response of cells to oxidative stress. LLA treatment significantly suppressed the generation of intracellular ROS when the cells were exposed to H2O2 (Fig. 7), indicating the potent anti-oxidative effect of LLA under conditions of pathological oxidative stress. Given that inflammation plays a major role in cancer development, and ROS is a critical factor in triggering inflammation and promoting cancer initiation and progression, we propose that LLA's cancer-preventive effect is largely attributed to its anti-oxidative and anti-inflammatory activities. Nonetheless, further investigations are warranted to elucidate the precise mechanisms underlying the action of LLA, and we plan to conduct these investigations in future studies.
Furthermore, while we observed LLA's anti-inflammatory and cancer-preventive effects, we discovered that the effect was not linearly dose-dependent. In both studies using the DSS-induced colitis model and AOM/DSS-induced mouse colon carcinogenesis model, 0.2% LLA showed the best effect, overwhelming both 0.07% and 0.6% (Figs 1−3). These findings provide evidence for an inverted 'U-shaped' dose response effect of LLA, where low to moderate concentrations exhibit anti-inflammatory properties, while higher doses may induce proinflammatory and cytotoxic effects. This observation may be attributed to the tumoricidal effects of the individual components within LLA, as discussed earlier. Interestingly, our in vitro cytotoxicity study revealed a striking discovery: LLA demonstrated a remarkable cytotoxic effect at concentrations exceeding 1 mg/ml (Fig. 5). This finding sheds light on the inverted U-shaped dose-response relationship of LLA and its potential implications. Furthermore, we found a similar phenomenon in our previous study using an extract mixture of Phellinus linteus, bamboo leaf, and chaga mushroom[8], and other researchers also reported similar findings using natural herbs[27]. However, the detailed mechanisms underlying this dose effect remain unclear, necessitating further investigations.
Although the cytotoxicity of LLA components has been reported in many cancer cells[5], we found no evidence of LLA cytotoxicity up to 1 mg/kg in either cancer or normal cells (Fig. 5). While these findings support our previously stated hypothesis that LLA's cancer-preventive effect is not due to its tumoricidal effect, they also support LLA's safety/nontoxicity as a supplemental drink.
Nowadays, various healthy supplements, including supplemental drinks originating from natural products and traditional Chinese medicines, have been used habitually for health-oriented purposes. While most studies regarding healthy supplements focus on the effect of a single component and active molecule in a supplement, it is also crucial to evaluate the compositive effect of the supplement as a whole under routine doses and usage. We thus believe that the current study provides insights into the effect of LLA and its future applications.